Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04593082 · ClinicalTrials.gov registry record

Obesity and Pediatric Multiple Sclerosis

A clinical trial of Multiple Sclerosis, sponsored by University of Virginia.

Recruiting
Registry status
116
Enrollment target
2
Study locations

NCT04593082 is a study of Multiple Sclerosis that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 116 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04593082, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by University of Virginia.

RECRUITING
Registry status
116 participants
Enrollment target
2
Study locations

Study Summary

Obesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is unknown. This study will evaluate the relationship between obesity, obesity-derived inflammatory mediators, and imaging metrics of MS severity in children. Understanding how childhood obesity contributes to MS severity/progression may yield fundamental insights into disease pathobiology - which may thereby lead to effective strategies for halting its progression in its earliest stages.

Conditions Studied

Study Locations (2)

Pennsylvania

  • Children's Hospital of Philadelphia - Philadelphia

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2021-06-03
Est. Completion 2025-06-01

Sponsor

University of Virginia

449 total trials

What the Registry Record Tells You About NCT04593082

The ClinicalTrials.gov registry entry for NCT04593082 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (80% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT04593082 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Virginia.

Frequently Asked Questions

What is clinical trial NCT04593082 about?

NCT04593082 is a clinical study titled "Obesity and Pediatric Multiple Sclerosis". Obesity is one possible contributor to severity of multiple sclerosis and progression of the disease. We already know that obesity is a risk determinant for acquiring MS, yet the impact of obesity on pediatric MS disease expression and course is unknown. This study will evaluate the relationship bet...

What is the current status of trial NCT04593082?

This trial is currently recruiting. The enrollment target is 116 participants. The study started on 2021-06-03. Estimated completion is 2025-06-01.

What conditions does trial NCT04593082 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT04593082?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04593082 being conducted?

This trial has 2 study locations across Pennsylvania, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.